BCHE and Mental deterioration: However, currently available cholinesterase inhibitors, such as donepezil, galantamine, rivastigmine, or tacrine, which were developed following the cholinergic hypothesis, are only able to slightly reduce the short-term cognitive decline in patients suffering from AD and have high withdrawal rates due to adverse effects [32].